Skip to main content
. 2009 Mar 24;20(12):2071–2078. doi: 10.1007/s00198-009-0912-3

Table 1.

Baseline characteristics by sex and ankle–brachial index groups

  Men Women
ABI > 0.9 (n = 456) ABI ≤ 0.90 (n = 70) P value ABI > 0.9 (n = 680) ABI ≤ 0.90 (n = 124) P value
Mean (SD) Percentage (%) Mean (SD) Percentage (%)   Mean (SD) Percentage (%) Mean (SD) Percentage (%)  
Age (years) 73.2 (8.7) 76.9 (9.0) 0.001 73.2 (9.0) 77.1 (11.3) <0.001
BMI (kg/m2) 26.2 (3.6) 25.4 (3.4) 0.10 24.7 (4.0) 24.1 (4.2) 0.16
SBP (mmHg) 136.7 (20.4) 142.4 (20.7) 0.03 138.6 (21.8) 145.7 (24.6) 0.001
Lipids
 Triglycerides 128.3 (86.7) 141.5 (136.8) 0.28 127.8 (70.7) 136.7 (77.0) 0.21
 Total cholesterol 196.8 (34.6) 200.2 (39.4) 0.46 215.5 (35.7) 217.1 (40.4) 0.66
 LDL 124.4 (29.6) 121.4 (34.0) 0.45 126.5 (33.1) 131.1 (40.0) 0.17
 HDL 48.9 (13.8) 49.7 (13.5) 0.67 65.3 (17.1) 60.4 (15.9) 0.003
 TC/HDL 4.28 (1.2) 4.27 (1.4) 0.98 3.5 (1.1) 3.8 (1.3) 0.003
Renal function
 CrCla 59.08 (57.6) 53.74 (49.88) 0.011 57.34 (56.1) 52.43 (49.6) 0.002
Lifestyle
 Exercise ≥3/week 79.3 67.1 0.02 72.2 59.7 0.005
 Current smoker 4.6 14.3 0.001 7.2 11.3 0.12
 Alcohol use ≥3/week 55.4 50.0 0.40 41.7 30.6 0.02
Medications
 Estrogen 42.9 30.6 0.01
 Calcium supp 21.5 8.6 0.01 51.5 36.3 0.002
 Vitamin D supp 8.8 4.3 0.20 20.0 15.3 0.23
 Thiazides 8.4 10.1 0.62 7.8 6.5 0.62
 Lipid lowering 11.7 14.5 0.51 12.6 14.8 0.52
 Beta blockers 10.1 13.4 0.40 11.2 13.8 0.42
 Calcium channel blocker 16.8 19.4 0.81 12.6 14.7 0.54
Medical history
 Hypertension 70.5 74.3 0.52 70.9 79.0 0.06
 Diabetes 9.2 15.7 0.09 5.6 9.7 0.08
 Chronic Kidney Diseaseb 41.7 56.7 0.021 64.5 75.4 0.021

aCreatinine clearance by the Cockcroft-Gault equation

bDefined as CrCl < 60 ml/min/1.73 m2